Literature DB >> 29124379

Use of the BREAST-Q™ Survey in the Prospective Evaluation of Reduction Mammaplasty Outcomes.

Isaias Vieira Cabral1, Edgard da Silva Garcia1, Rebecca Neponucena Sobrinho2, Natália Lana Larcher Pinto1, Yara Juliano3,4, Joel Veiga-Filho1, Lydia Masako Ferreira5, Daniela Francescato Veiga6,7.   

Abstract

INTRODUCTION: BREAST-Q™ is a patient-reported outcomes survey instrument with a specific module that evaluates breast reduction surgery. It allows assessment of patient's satisfaction with received treatment and evaluates the impact of surgery on different aspects of the patient's quality of life. This article aims to assess the satisfaction and quality of life of patients who underwent reduction mammaplasty.
MATERIALS AND METHODS: Women aged between 18 and 60 years, with a body mass index ranging from 19 to 30 kg/m2, who were already scheduled for reduction mammaplasty, were included in the study. The Brazilian version of the BREAST-Q™ Reduction/Mastopexy Module (preoperative 1.0 and postoperative 1.0 versions) was self-applied preoperatively and 1 and 6 months after the operation.
RESULTS: One hundred and seven patients were included in the study and completed the 6-month follow-up. The median age was 33 years, and the median preoperative body mass index was 25 kg/m2. The superomedial pedicle was used in 96.3% of the cases, and the total median weight of the resected breast was 1115 g. There was a significant improvement in the scores of the scales: Psychosocial well-being, Sexual well-being, Physical well-being, and Satisfaction with the breasts compared to the preoperative assessment (p < 0.0001). The scales Satisfaction with the NAC and Satisfaction with the outcome, available only in the postoperative version, demonstrated high satisfaction rates at the two postoperative periods evaluated.
CONCLUSION: Reduction mammaplasty improved the quality of life and provided high levels of patient satisfaction with outcomes 1 and 6 months postoperatively. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Entities:  

Keywords:  Breast; Mammaplasty; Outcome assessment; Patient satisfaction; Quality of life; Surgery, plastic

Mesh:

Year:  2017        PMID: 29124379     DOI: 10.1007/s00266-017-1009-6

Source DB:  PubMed          Journal:  Aesthetic Plast Surg        ISSN: 0364-216X            Impact factor:   2.326


  3 in total

1.  Breast cancer patient-reported outcomes on level 1 and level 2 oncoplastic procedures using BREAST-Q®.

Authors:  C A Pinto; B Peleteiro; C S Pinto; F Osório; S Costa; A Magalhães; H Mora; J Amaral; D Gonçalves; J L Fougo
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-29       Impact factor: 4.322

2.  Use of Absorbable Dermal Stapler in Reduction Mammoplasty: Assessing Technical, Quality-of-Life, and Aesthetics Outcomes.

Authors:  Viren Patel; Jason L Green; Adrienne N Christopher; Martin P Morris; Eric S Weiss; Robyn B Broach; Paris D Butler
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-08-25

3.  Single dose versus 24 h antibiotic prophylaxis in reduction mammaplasty: study protocol for a randomized controlled trial.

Authors:  Daniela Francescato Veiga; Edgard da Silva Garcia; José Wilson Moreira-Filho; Evelyne Borges de Mattos Andrade; Yara Juliano; Joel Veiga-Filho; Lydia Masako Ferreira
Journal:  Trials       Date:  2020-07-02       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.